Our NanoNews Digest Sponsors
Home > Directory > Products and applications > Salzburg Therapeutics
Salzburg Therapeutics
Salzburg Therapeutics is committed to developing Cytotoxamer and Genotoxamer technologies and to obtaining FDA approval to initiate human clinical trials with our lead compound. We seek funding for our drug development efforts through a combination of government grants and private equity. Salzburg Therapeutics welcomes inquiries from larger pharmaceutical companies seeking to expand their pipeline for developing new oncology products.
3455 University Parkway
Winston-Salem, NC 27106 USA
336-831-5686
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||